JVMCX
Price
$29.00
Change
+$0.25 (+0.87%)
Updated
Sep 11 closing price
Net Assets
23.18B
LYRIX
Price
$33.95
Change
+$0.77 (+2.32%)
Updated
Sep 11 closing price
Net Assets
1.3B
Interact to see
Advertisement

JVMCX vs LYRIX

JVMCX vs LYRIX Comparison Chart in %
View a ticker or compare two or three
VS
JVMCX vs. LYRIX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMCX is a Buy and LYRIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMCX has more cash in the bank: 23.2B vs. LYRIX (1.3B). LYRIX pays higher dividends than JVMCX: LYRIX (0.15) vs JVMCX (0.00). JVMCX was incepted earlier than LYRIX: JVMCX (15 years) vs LYRIX (14 years). JVMCX (1.86) is less costly to investors than LYRIX (0.98). JVMCX is a more actively managed with annual turnover of: 48.00 vs. LYRIX (32.00). JVMCX has a lower initial minimum investment than LYRIX: JVMCX (1000) vs LYRIX (100000). LYRIX annual gain was more profitable for investors over the last year : 9.45 vs. JVMCX (0.77). LYRIX return over 5 years is better than : 56.54 vs. JVMCX (9.33).
JVMCXLYRIXJVMCX / LYRIX
Total Expense Ratio1.850.99187%
Annual Report Gross Expense Ratio1.860.98190%
Fund Existence15 years14 years-
Gain YTD12.39214.96983%
Front LoadN/AN/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets23.2B1.3B1,786%
Annual Yield % from dividends0.000.15-
Returns for 1 year0.779.458%
Returns for 3 years16.3263.9026%
Returns for 5 years9.3356.5417%
Returns for 10 years45.22125.1736%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTHCX17.96N/A
N/A
Invesco Health Care C
HSRUX30.10N/A
N/A
Carillon Eagle Small Cap Growth R6
ESCFX18.42N/A
N/A
1290 Essex Small Cap Growth A
OIERX28.64N/A
N/A
JPMorgan Equity Income R5
PMJPX13.54N/A
N/A
PIMCO RAE US Small I-2